
AMWL
USDAmerican Well Corporation Class A Common Stock
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$4.230
Máximo
$4.280
Mínimo
$4.100
Volumen
0.21M
Fundamentos de la Empresa
Capitalización de Mercado
67.6M
Industria
Health Information Services
País
United States
Estadísticas de Negociación
Volumen Promedio
0.08M
Bolsa
NYQ
Moneda
USD
Rango de 52 Semanas
Informe de Análisis de IA
Última actualización: 2 nov 2025AMWL Stock Analysis: American Well at Critical Support Level (November 2025)
Price Action Review
American Well (AMWL) has been in a downward spiral since August 2025, dropping from $7.01 to a 52-week low of $5.13 by October 30th. Key patterns observed:
- 87% crash from August high ($8.65) to October low ($5.13)
- Double-bottom formation at $5.13-$5.15 support zone (Oct 30-Nov 1)
- Volume spikes during decline (149k shares on Oct 10, 106k on Oct 22)
- Recent consolidation around $5.22 after hitting the 52-week low
Fundamental Snapshot
| Metric | Value | Commentary |
|---|---|---|
| Market Cap | $84.3M | Micro-cap stock (high risk) |
| P/E Ratio | -0.68x | "Better" than industry (-1.0x) |
| Return on Equity | -37.6% | Severe profitability issues |
| Debt-to-Equity | 2.17x | Exceeds healthy thresholds |
| Revenue Growth | 12.9% | Modest growth for healthcare tech |
Technical Indicators
- Bullish Breakout Signals
- Price hugging $5.15 support level
- MACD crossover (0.0056 > signal line 0.0001)
- On-Balance Volume surged to 4.7x average
- ADX at 9.2 suggests weak trend strength
- Critical Levels
- Support: $5.11 (recent low)
- Resistance: $5.31 (near take-profit level)
- Stop-loss: $4.69 (9% below entry)
Strategic Guidance
Buy Signal: $5.13-$5.19 range Take Profit: $5.31 (+3.5% target) Stop Loss: $4.69 (-8.5% risk) Hold Period: 1-2 weeks
Setup suggests a potential bounce from historic lows, though with limited upside projection. Traders should consider position sizing no more than 1-2% of portfolio given risk factors.
Risk Considerations
⚠️ Medium-High Risk Profile:
- Low Volatility: Makes breakout confirmation difficult
- Micro-Cap Status: Limited liquidity ($75k average volume)
- Fundamental Weakness: Negative ROE and high debt-to-equity ratio
- 52-week low trade: No margin for error at this support level
Current Outlook
While technicals show classic signs of short-term bottoming (volume surge + MACD crossover), fundamentals remain deeply problematic. The recommendation appears based primarily on bargain-hunting potential at extreme levels rather than business quality.
Given the AI prediction score of 0.0, traders should treat this as a pure technical play rather than fundamentals-driven growth opportunity. The neutral sentiment score and lack of news events suggest price action will be driven by technical factors and broader market conditions.
Action: Consider small-scale entry near $5.13 with strict risk management Timing: Setup valid for 19 more days (through Nov 21) Caution: Negative fundamentals make this a speculative trade
*This analysis is based solely on structured data dated 2025-11-02. Always verify current
Noticias Relacionadas
Amwell® Announces Results for Third Quarter 2025
BOSTON , Nov. 04, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, today announced financial results for the third
Predicción de IABeta
Recomendación de IA
Actualizado el: 10 nov 2025, 15:20
69.0% Confianza
Riesgo y Negociación
Punto de Entrada
$4.15
Toma de Ganancias
$4.27
Stop Loss
$3.77
Factores Clave
Acciones Relacionadas
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.